Age, mean±SD | 38.5±10.4 | 36.6±12.2 | 37.1±10.1 | 37.8±11.8 | 38.7±11.4 | 34.3±10.8 | 37.6±11.1 | 37.5±12.1 | 35.4±11.1 | 38.9±11.3 |
P-values | 0.37 | 0.77 | 0.08 | 0.97 | 0.12 |
Gender (n=91) | 48 | 43 | 26 | 65 | 67 | 24 | 67 | 24 | 34 | 57 |
P-values | 0.84 | 0.77 | 0.52 | 0.16 | 0.99 |
Cutaneous (n=83) | 45 | 38 | 25 | 58 | 61 | 22 | 59 | 24 | 31 | 52 |
P-values | 0.47 | 0.37 | 0.57 | 0.98 | 0.99 |
Arthritis (n=86) | 44 | 42 | 23 | 63 | 62 | 24 | 61 | 25 | 33 | 53 |
P-values | 0.62 | 0.55 | 0.20 | 0.96 | 0.67 |
Serositis (n=20) | 6 | 14 | 4 | 16 | 18 | 2 | 15 | 5 | 8 | 12 |
P-values | 0.03 | 0.37 | 0.08 | 0.66 | 0.79 |
Renal (n=50) | 29 | 21 | 19 | 31 | 35 | 15 | 38 | 12 | 20 | 30 |
P-values | 0.27 | 0.03 | 0.29 | 0.29 | 0.60 |
Neurological (n=19) | 7 | 12 | 2 | 17 | 16 | 3 | 13 | 6 | 10 | 9 |
P-values | 0.14 | 0.06 | 0.30 | 0.78 | 0.13 |
Hematological (n=47) | 23 | 24 | 14 | 33 | 32 | 15 | 34 | 13 | 22 | 25 |
P-values | 0.53 | 0.72 | 0.16 | 0.79 | 0.07 |
Immunological (n=92) | 45 | 47 | 24 | 68 | 68 | 24 | 66 | 26 | 36 | 56 |
P-values | 0.08 | 0.27 | 0.61 | 0.69 | 0.35 |
Values are presented as numbers or proportion in a subgroup. P-values (Bonferroni-adjusted) below 0.05 represents a statistically significant relationship (contingency) between CYP2D6 genotypes and participant characteristics. CYP2D6: cytochrome P450 2D6, SD: standard deviation, SNP: single nucleotide polymorphism, CYP2D6 SNP genotype 0: reference variant (homozygous dominant), CYP2D6 SNP genotype 1: alternative variants (heterozygous and homozygous recessive) |